Plasma apolipoprotein A1 as a biomarker for Parkinson disease-Reference-Cited by-同舟云学术

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

Published:2013-07 Issue:1 Volume:74 Page:119-127
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Qiang Judy K.¹,Wong Yvette C.¹,Siderowf Andrew²,Hurtig Howard I.¹,Xie Sharon X.³,Lee Virginia M.-Y.⁴,Trojanowski John Q.⁴,Yearout Dora,B. Leverenz James,Montine Thomas J.⁵,Stern Matt,Mendick Susan,Jennings Danna,Zabetian Cyrus,Marek Ken,Chen-Plotkin Alice S.¹

Affiliation:

1. Department of Neurology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia; PA

2. Avid Radiopharmaceuticals; Philadelphia; PA

3. Departments of Biostatistics and Epidemiology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia; PA

4. Pathology and Laboratory Medicine; Perelman School of Medicine at the University of Pennsylvania; Philadelphia; PA

5. Pathology; University of Washington School of Medicine; Seattle; WA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference41 articles.

1. Onset age of Parkinson disease;Inzelberg;Am J Med Genet,2002

2. Ageing and Parkinson's disease: substantia nigra regional selectivity;Fearnley;Brain,1991

3. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects;Shaw;Ann Neurol,2009

4. Apolipoprotein E genotype and Alzheimer's disease;Payami;Lancet,1993

5. The Parkinson Progression Marker Initiative (PPMI);Parkinson Progression Marker Initiative;Prog Neurobiol,2011

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome-based biomarker prediction for Parkinson’s disease using genome-scale metabolic modeling;Scientific Reports;2024-01-05

2. Differential Expression of Fibrinogen Alpha and Its Potential Involvement in Osteoarthritis Pathogenesis;Molecular Biotechnology;2024-01-05

3. Unmasking Hidden Systemic Effects of Neurodegenerative Diseases: A Two-Pronged Approach to Biomarker Discovery;2023-11-24

4. Diagnostic Biomarkers of Parkinson's Disease;Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease;2023-08-04

5. Pros and cons for statins use and risk of Parkinson's disease: An updated perspective;Pharmacology Research & Perspectives;2023-02-22